We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
276
Church & Dwight Co
CHD
$23.5B
$5.81M 0.08%
77,168
+14,250
+23% +$1.08M
SPG icon
277
Simon Property Group
SPG
$74.7B
$5.75M 0.08%
36,930
-2,338
-6% -$364K
VEEV icon
278
Veeva Systems
VEEV
$32.1B
$5.73M 0.08%
37,511
-7,231
-16% -$1.16M
A icon
279
Agilent Technologies
A
$39B
$5.67M 0.08%
74,058
-13,587
-16% -$980K
PFG icon
280
Principal Financial Group
PFG
$23.9B
$5.67M 0.08%
99,138
+56,129
+131% +$3.16M
CPAY icon
281
Corpay
CPAY
$25B
$5.65M 0.07%
19,692
+6,884
+54% +$2M
MRSH
282
Marsh
MRSH
$87.9B
$5.63M 0.07%
56,303
+2,633
+5% +$263K
CNI icon
283
Canadian National Railway
CNI
$78.1B
$5.62M 0.07%
62,555
+75
+0.1% +$6.93K
SGMO
284
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$5.57M 0.07%
615,000
+200,000
+48% +$2.24M
ROP icon
285
Roper Technologies
ROP
$37.5B
$5.49M 0.07%
15,388
+343
+2% +$125K
UGI icon
286
UGI
UGI
$7.93B
$5.49M 0.07%
109,156
+62,231
+133% +$3.11M
PH icon
287
Parker-Hannifin
PH
$124B
$5.45M 0.07%
30,186
+3,302
+12% +$562K
TBPH icon
288
Theravance Biopharma
TBPH
$875M
$5.45M 0.07%
279,700
– –
IPG
289
DELISTED
Interpublic Group of Companies
IPG
$5.35M 0.07%
248,160
+55,643
+29% +$1.2M
MKC icon
290
McCormick & Company Non-Voting
MKC
$13.7B
$5.34M 0.07%
68,352
-13,502
-16% -$1.08M
DINO icon
291
HF Sinclair
DINO
$16.4B
$5.34M 0.07%
99,554
+15,841
+19% +$768K
ITW icon
292
Illinois Tool Works
ITW
$81.9B
$5.34M 0.07%
34,122
+1,199
+4% +$182K
ARVN icon
293
Arvinas
ARVN
$535M
$5.3M 0.07%
+245,791
New +$6.03M
PBA icon
294
Pembina Pipeline
PBA
$29.2B
$5.24M 0.07%
141,208
+10,335
+8% +$383K
PTLA
295
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.21M 0.07%
194,300
– –
ZTS icon
296
Zoetis
ZTS
$32.4B
$5.2M 0.07%
41,710
+834
+2% +$101K
WMT icon
297
Walmart Inc
WMT
$888B
$5.18M 0.07%
131,061
-7,761
-6% -$293K
BKR icon
298
Baker Hughes
BKR
$60.1B
$5.18M 0.07%
223,097
+21,485
+11% +$504K
CCL icon
299
Carnival Corporation Ltd
CCL
$36.6B
$5.13M 0.07%
117,482
-67,325
-36% -$3.11M
ATO icon
300
Atmos Energy
ATO
$29.7B
$5.11M 0.07%
44,822
+2,808
+7% +$307K
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.